Ontology highlight
ABSTRACT: Importance
Many patients with diabetic peripheral neuropathy experience chronic pain and inadequate relief despite best available medical treatments.Objective
To determine whether 10-kHz spinal cord stimulation (SCS) improves outcomes for patients with refractory painful diabetic neuropathy (PDN).Design, setting, and participants
The prospective, multicenter, open-label SENZA-PDN randomized clinical trial compared conventional medical management (CMM) with 10-kHz SCS plus CMM. Participants with PDN for 1 year or more refractory to gabapentinoids and at least 1 other analgesic class, lower limb pain intensity of 5 cm or more on a 10-cm visual analogue scale (VAS), body mass index (calculated as weight in kilograms divided by height in meters squared) of 45 or less, h
SUBMITTER: Petersen EA
PROVIDER: S-EPMC8022268 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature